Kent Lake PR’s AngioDynamics ANGO Stock Holding History

Kent Lake PR’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000,000	Closed	-$7.78M	–	42
2024 Q3	$7.78M	Buy	+1,000,000	New	+$7.22M	3.09%	14

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kent Lake PR's ANGO Position: Q4 2024 in Review

Kent Lake PR sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 1,000,000 shares — an estimated $7.78M sold.

Kent Lake PR first reported a position in ANGO in Q3 2024 and held it in 1 quarter. The position peaked at $7.78M in Q3 2024. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

Kent Lake PR reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
Kent Lake PR sold 1,000,000 AngioDynamics shares in Q4 2024, an estimated $7.78M.
Kent Lake PR first reported a position in AngioDynamics in Q3 2024 and held it in 1 quarter.
Kent Lake PR's AngioDynamics position peaked at $7.78M in Q3 2024.
135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Kent Lake PR's 13F filing for Q4 2024, filed 14 Feb 2025.